The long-term objective of the research is to determine the structural basis underlying the suggested biological effects mediated by mammalian HMG-I proteins. HMG-I is the principal member of an isoform group (the HMGI family) of the nuclear proteins and is the first mammalian nonhistone protein demonstrated to specifically bind, both in vitro and in vivo, to A T-rich regions of DNA. Recent reports indicate that all types of cancerous cells contain exceptionally high concentrations of HMGI proteins which have been proposed to be biochemical markers for the transformed state. In vitro, members of the HMGI family have been demonstrated to act as gene transcription stimulatory factors and also to specifically bind to important A.T-rich DNA regulatory regions, including gene promoters, enhancers and the DNA replication origins of several organisms. A peptide """"""""binding domain"""""""" (BD) common to all known HMGI proteins has been identified that mediates binding of these proteins to the narrow minor groove of DNA and is called """"""""A T-hook"""""""" because of its novel predicted secondary structure. In certain ways the BD peptide resembles the antitumor/antiviral drugs distamycin, netropsin and the dye Hoechst 33258, ligands which effectively compete with HMGI proteins for DNA binding both in vitro and in vivo. Individual HMGI proteins have three separate BD peptide motifs. Both in vitro and in vivo, HMGI proteins are preferred substrates for the cell division regulating enzyme cdc2 kinase which specifically phosphorylates the """"""""hook"""""""" region of the BD peptides. In vitro such phosphorylation has been demonstrated to significantly weaken the DNA binding affinity of both synthetic BD peptides and intact HMGI proteins.
Specific Aims of Project: (1) To determine the 3D solution structure of both the unphosphorylated and cdc2 kinase phosphorylated synthetic BD peptides employing 2D NMR techniques; (2) Determine the effects of specific deletions, duplications or mutations in one or more of the individual BD peptides present in wild type (wt) HMG-I proteins on the ability of such mutant proteins to strongly and specifically interact with A T-rich DNA. (3) Produce recombinant hybrid BD-peptide/""""""""tag-peptide"""""""" fusion proteins and determine whether these hybrid proteins can specifically """"""""target"""""""" and bind to stretches of A T-rich sequence in vitro and in vivo. The results of these studies will not only help establish the structural basis for understanding the biological effects of an important group of proteins, but will also contribute new detailed information about general molecular mechanisms involved in specific DNA-protein interactions. And, perhaps as importantly, the experiments may establish a mechanism for """"""""targeting"""""""" specific peptides or proteins A T-rich sequences in living cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM046352-01
Application #
3305771
Study Section
Molecular Biology Study Section (MBY)
Project Start
1991-08-01
Project End
1994-07-31
Budget Start
1991-08-01
Budget End
1992-07-31
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Washington State University
Department
Type
Schools of Arts and Sciences
DUNS #
041485301
City
Pullman
State
WA
Country
United States
Zip Code
99164
Adair, Jennifer E; Kwon, Youngho; Dement, Gregory A et al. (2005) Inhibition of nucleotide excision repair by high mobility group protein HMGA1. J Biol Chem 280:32184-92
Dement, Gregory A; Treff, Nathan R; Magnuson, Nancy S et al. (2005) Dynamic mitochondrial localization of nuclear transcription factor HMGA1. Exp Cell Res 307:388-401
Edberg, Dale D; Adkins, Joshua N; Springer, David L et al. (2005) Dynamic and differential in vivo modifications of the isoform HMGA1a and HMGA1b chromatin proteins. J Biol Chem 280:8961-73
Treff, Nathan R; Pouchnik, Derek; Dement, Gregory A et al. (2004) High-mobility group A1a protein regulates Ras/ERK signaling in MCF-7 human breast cancer cells. Oncogene 23:777-85
Edberg, Dale D; Bruce, James E; Siems, William F et al. (2004) In vivo posttranslational modifications of the high mobility group A1a proteins in breast cancer cells of differing metastatic potential. Biochemistry 43:11500-15
Treff, Nathan R; Dement, Gregory A; Adair, Jennifer E et al. (2004) Human KIT ligand promoter is positively regulated by HMGA1 in breast and ovarian cancer cells. Oncogene 23:8557-62
Beckerbauer, Lois; Tepe, Jetze J; Eastman, Rebecca A et al. (2002) Differential effects of FR900482 and FK317 on apoptosis, IL-2 gene expression, and induction of vascular leak syndrome. Chem Biol 9:427-41
Attema, Joanne L; Reeves, Raymond; Murray, Vincent et al. (2002) The human IL-2 gene promoter can assemble a positioned nucleosome that becomes remodeled upon T cell activation. J Immunol 169:2466-76
Reeves, R; Edberg, D D; Li, Y (2001) Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells. Mol Cell Biol 21:575-94
Pedulla, M L; Treff, N R; Resar, L M et al. (2001) Sequence and analysis of the murine Hmgiy (Hmga1) gene locus. Gene 271:51-8

Showing the most recent 10 out of 25 publications